Elevance Health Inc (ELV)

Pretax margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before tax but after interest (EBT) (ttm) US$ in thousands 7,904,000 8,299,000 8,580,000 8,035,000 7,715,000 7,868,000 8,360,000 8,062,000 7,769,000 8,015,000 7,865,000 8,075,000 7,925,000 7,136,000 5,529,000 6,325,000 6,238,000 6,725,000 7,825,000 6,129,000
Revenue (ttm) US$ in thousands 176,810,000 174,015,000 171,719,000 171,745,000 171,340,000 167,687,000 164,777,000 159,737,000 155,660,000 151,551,000 147,434,000 142,653,000 136,943,000 133,882,000 129,218,000 124,631,000 121,867,000 117,450,000 112,966,000 109,168,000
Pretax margin 4.47% 4.77% 5.00% 4.68% 4.50% 4.69% 5.07% 5.05% 4.99% 5.29% 5.33% 5.66% 5.79% 5.33% 4.28% 5.07% 5.12% 5.73% 6.93% 5.61%

December 31, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $7,904,000K ÷ $176,810,000K
= 4.47%

Elevance Health Inc's pretax margin has shown some fluctuation over the period from March 31, 2020, to December 31, 2024. The pretax margin measures the company's profitability before taxes relative to its total revenue, reflecting its ability to control operating costs and generate profits.

The company's pretax margin ranged from a low of 4.28% on June 30, 2021, to a high of 6.93% on June 30, 2020. Although there were fluctuations, the pretax margin generally remained within a relatively narrow range between 4.28% and 6.93%.

It is noteworthy that the pretax margin experienced a decrease towards the end of the period, with a decrease from 5.33% on June 30, 2022, to 4.47% on December 31, 2024. This decrease may indicate challenges in controlling operating expenses or generating higher revenues during this period.

Overall, the trend in Elevance Health Inc's pretax margin suggests that the company has been able to maintain a moderate level of profitability over the years, with periodic fluctuations that may require further analysis to understand the underlying factors affecting the company's financial performance.